Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Urinary proteomic analysis of chronic allograft nephropathy.

O'Riordan E, Orlova TN, Mendelev N, Patschan D, Kemp R, Chander PN, Hu R, Hao G, Gross SS, Iozzo RV, Delaney V, Goligorsky MS.

Proteomics Clin Appl. 2008 Jul;2(7-8):1025-35. doi: 10.1002/prca.200780137.

2.

Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods.

Johnston O, Cassidy H, O'Connell S, O'Riordan A, Gallagher W, Maguire PB, Wynne K, Cagney G, Ryan MP, Conlon PJ, McMorrow T.

Proteomics Clin Appl. 2011 Aug;5(7-8):422-31. doi: 10.1002/prca.201000160. Epub 2011 Jul 13.

PMID:
21751411
3.

Characterization of renal allograft rejection by urinary proteomic analysis.

Clarke W, Silverman BC, Zhang Z, Chan DW, Klein AS, Molmenti EP.

Ann Surg. 2003 May;237(5):660-4; discussion 664-5.

4.

Urinary beta2-microglobulin is associated with acute renal allograft rejection.

Oetting WS, Rogers TB, Krick TP, Matas AJ, Ibrahim HN.

Am J Kidney Dis. 2006 May;47(5):898-904.

PMID:
16632030
5.

Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology.

Schaub S, Mayr M, Hönger G, Bestland J, Steiger J, Regeniter A, Mihatsch MJ, Wilkins JA, Rush D, Nickerson P.

Transplantation. 2007 Jul 15;84(1):104-12.

PMID:
17627245
6.

Proteomic profiling of renal allograft rejection in serum using magnetic bead-based sample fractionation and MALDI-TOF MS.

Sui W, Huang L, Dai Y, Chen J, Yan Q, Huang H.

Clin Exp Med. 2010 Dec;10(4):259-68. doi: 10.1007/s10238-010-0094-5. Epub 2010 Apr 8.

PMID:
20376689
7.

LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.

Surin B, Sachon E, Rougier JP, Steverlynck C, Garreau C, Lelongt B, Ronco P, Piedagnel R.

Proteomics. 2013 Jan;13(1):142-52. doi: 10.1002/pmic.201200267. Epub 2012 Dec 18.

PMID:
23161552
8.

Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy.

Rocchetti MT, Papale M, d'Apollo AM, Suriano IV, Di Palma AM, Vocino G, Montemurno E, Varraso L, Grandaliano G, Di Paolo S, Gesualdo L.

Clin J Am Soc Nephrol. 2013 Jul;8(7):1115-25. doi: 10.2215/CJN.05950612. Epub 2013 Apr 18.

9.

Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.

Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y.

Diabetes Metab Res Rev. 2009 Mar;25(3):232-41. doi: 10.1002/dmrr.940.

PMID:
19177462
10.

Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood.

Woroniecki RP, Orlova TN, Mendelev N, Shatat IF, Hailpern SM, Kaskel FJ, Goligorsky MS, O'Riordan E.

Am J Nephrol. 2006;26(3):258-67. Epub 2006 Jun 7.

PMID:
16763371
11.

Proteomic analysis of urine from male dogs during early stages of tubulointerstitial injury in a canine model of progressive glomerular disease.

Nabity MB, Lees GE, Dangott LJ, Cianciolo R, Suchodolski JS, Steiner JM.

Vet Clin Pathol. 2011 Jun;40(2):222-36. doi: 10.1111/j.1939-165X.2011.00307.x. Epub 2011 Mar 29.

PMID:
21446987
12.

Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy.

Papale M, Di Paolo S, Magistroni R, Lamacchia O, Di Palma AM, De Mattia A, Rocchetti MT, Furci L, Pasquali S, De Cosmo S, Cignarelli M, Gesualdo L.

Diabetes Care. 2010 Nov;33(11):2409-15. doi: 10.2337/dc10-0345. Epub 2010 Jul 29.

14.

An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome.

Bates WD, Davies DR, Welsh K, Gray DW, Fuggle SV, Morris PJ.

Nephrol Dial Transplant. 1999 Oct;14(10):2364-9.

15.

Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy.

Shin JR, Kim SM, Yoo JS, Park JY, Kim SK, Cho JH, Jeong KH, Lee TW, Ihm CG.

Korean J Intern Med. 2014 May;29(3):334-40. doi: 10.3904/kjim.2014.29.3.334. Epub 2014 Apr 29.

16.

Bioinformatic analysis of the urine proteome of acute allograft rejection.

O'Riordan E, Orlova TN, Mei J J, Butt K, Chander PM, Rahman S, Mya M, Hu R, Momin J, Eng EW, Hampel DJ, Hartman B, Kretzler M, Delaney V, Goligorsky MS.

J Am Soc Nephrol. 2004 Dec;15(12):3240-8.

17.

Urinary β2-Microglobulin Is a Good Indicator of Proximal Tubule Injury: A Correlative Study with Renal Biopsies.

Zeng X, Hossain D, Bostwick DG, Herrera GA, Zhang PL.

J Biomark. 2014;2014:492838. doi: 10.1155/2014/492838. Epub 2014 Nov 20.

18.

Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques.

Yehia M, Matheson PJ, Merrilees MJ, Beaumont BW, Pilmore HL.

Nephrology (Carlton). 2006 Jun;11(3):261-6.

PMID:
16756643
19.

Proteomic analysis of rat plasma by SELDI-TOF-MS under the condition of prevention of progressive adriamycin nephropathy using oral adsorbent AST-120.

Ishikawa I, Hayama T, Yoshida S, Asaka M, Tomosugi N, Watanabe M, Yamato H, Sugano M.

Nephron Physiol. 2006;103(3):p125-30. Epub 2006 Mar 23.

PMID:
16557031
20.

Urine periostin as a biomarker of renal injury in chronic allograft nephropathy.

Satirapoj B, Witoon R, Ruangkanchanasetr P, Wantanasiri P, Charoenpitakchai M, Choovichian P.

Transplant Proc. 2014 Jan-Feb;46(1):135-40. doi: 10.1016/j.transproceed.2013.07.069.

PMID:
24507039
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk